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Cathepsinirus (MMTV) is a pH-dependent virus that uses mouse transferrin receptor 1
(TfR1) for entry into cells. Previous studies demonstrated that MMTV could induce pH 5-dependent fusion-
from-with of mouse cells. Here we show that the MMTV envelope-mediated cell–cell fusion requires both
the entry receptor and low pH (pH 5). Although expression of the MMTV envelope and TfR1 was sufﬁcient
to mediate low pH-dependent syncytia formation, virus infection required trafﬁcking to a low pH
compartment; infection was independent of cathepsin-mediated proteolysis. Human TfR1 did not support
virus infection, although envelope-mediated syncytia formation occurred with human cells after pH 5
treatment and this fusion depended on TfR1 expression. However, although the MMTV envelope bound
human TfR1, virus was only internalized and trafﬁcked to a low pH compartment in cells expressing mouse
TfR1. Thus, while human TfR1 supported cell–cell fusion, because it was not internalized when bound to
MMTV, it did not function as an entry receptor. Our data suggest that MMTV uses TfR1 for all steps of entry:
cell attachment, induction of the conformational changes in Env required for membrane fusion and
internalization to an appropriate acidic compartment.
© 2008 Elsevier Inc. All rights reserved.IntroductionInfection of mice by mouse mammary tumor virus (MMTV) has
long been known to cause mammary tumors in mice. Whether a
similar infectious agent exists in humans has been a subject of debate
since the discovery of MMTV. There have been reports that continuous
passage of MMTV on human breast cancer cell lines resulted in
adapted viruses that could infect human cells (Howard and Schlom,
1980; Lasfargues et al., 1979) and more recently, Indik et al. reported
infection of several human cell lines with a GFP-marked MMTV(Indik
et al., 2005). Additionally, several groups have detected MMTV-like
sequences in up to 40% of human breast cancer samples, but not
normal tissue (Etkind et al., 2000; Ford et al., 2003; Liu et al., 2001;
Pogo et al., 1999; Szabo et al., 2005; Wang et al., 1995; Zammarchi et
al., 2006). MMTV-like sequences have also been detected in patients
with the autoimmune disease, primary biliary cirrhosis (PBC) (Xu et
al., 2003). Other groups, however, have been unable to ﬁnd such
sequences (Bindra et al., 2007; Mant et al., 2004; Selmi et al., 2004).
Mouse transferrin receptor 1 (mTfR1) is the MMTV entry receptor
(Ross et al., 2002). Althoughmouse and humanTfR1 (hTfR1) show 76%s).
l rights reserved.identity and 86% homology at the amino acid level, we have shown
that the human receptor does not serve as an entry receptor. By
constructing human/mouse chimeric TfR1 molecules, we mapped the
critical amino acids required to support MMTV entry to two adjacent
regions in the extra-cellular domain of mouse TfR1 that are distinct
from the transferrin binding site (Wang et al., 2006).
Previous studies also demonstrated that MMTV is a pH-dependent
virus, since infection can be efﬁciently blocked by inhibitors that block
acidiﬁcation of intra-cellular compartments (Ross et al., 2002). As
exempliﬁed by inﬂuenza A virus, virus/cell membrane fusion required
for entry of low pH-dependent viruses occurs at the endosomal
membrane following receptor-mediated endocytosis (Skehel and
Wiley, 2000). Such intra-cellular fusion events can often be mimicked
at the cell surface by treating cells expressing viral fusionproteinswith
low pH buffer, resulting in syncytia formation (Redmond et al., 1984).
We show here that MMTV requires trafﬁcking to a low pH
compartment to achieve infection of cells and that this trafﬁcking
did not require Eps15, which is known to play a role in clathrin-
mediated endocytosis (Benmerah et al.,1999) or the recently identiﬁed
transferrin receptor transport protein (TTP) (Tosoni et al., 2005). We
also show that althoughMMTVusesmTfR1 andnot hTfR1 for infection,
low pH induced cell–cell fusion occurred on human cells that express
the MMTV envelope (Env) and both Env and hTfR1 were required for
this event. However, MMTV was unable to mediate internalization of
Fig. 1. MMTV induces low pH-dependent cell–cell fusion. (A) Syncytia formation requires MMTV Env expression and low pH. Mm5MT cells were grown in the presence (Dex+) or
absence (Dex−) of dexamethasone for 24 h and exposed to pH 5 or pH 7 media. A Western blot of cell extracts from duplicate wells grown in the absence or presence of
dexamethasone probed with anti-SU antisera is also shown. (B and C) Maximum cell–cell fusion pH occurs at pH 5. Mm5MT cells induced overnight with dexamethasone were
treated withmedia at the indicated pH. Twenty-four hours later, the cells were stainedwith Giemsa and the percentage of cells in syncytia (B) and the number of nuclei/syncytium (C)
were determined by counting.
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compartment to enter cells, it was unable to infect human cells despite
engaging the hTfR1 receptor. These data provide further evidence that
MMTV is unlikely to be a causal agent in human breast cancer.
Results
MMTV induces syncytia formation at low pH
Previously, we showed that MMTV infection required a low pH
compartment, since treatment of cells with lysosomotropic agentsFig. 2. Low pH treatment does not inactivateMMTV or release virus from the cell. (A) Pseudov
to infect mTfR1/293T cells. (B) Low pH does not release virus from the cell surface. Pseudoviru
then infection at 37 °C was allowed to proceed. Colonies were counted 48 h later.inhibited infection by viral pseudotypes (Ross et al., 2002). To further
examine the pH requirements of MMTV infection, we used a cell–cell
fusion assay similar to that described by Redmond et al. with the
Mm5MT murine mammary carcinoma cell line, derived from an
MMTV-induced mammary tumor (Redmond et al., 1984). Mm5MT
cells were grown in the presence or absence of the synthetic
glucocorticoid dexamethasone to induce viral protein expression
(Fig. 1A) and then treated with pH 5 media for 15 min; we determined
experimentally that 15 min incubation gave the highest levels of
fusion (not shown). Only dexamethasone-induced cells expressing
high levels of Env and treated with pH 5 media showed syncytiairions were incubated for 15 min at 37 °C at the indicated pH, neutralized and then used
ses were incubated with mTfR1/293T cells for 1 h at 4 °C, pulsed at the indicated pH and
232 E. Wang et al. / Virology 381 (2008) 230–240formation; hormone-stimulated cells that expressed the same levels
of Env but incubated at pH 7 demonstrated no syncytia (Fig. 1A).
To determine which pH induced maximum cell–cell fusion, we
incubated dexamethasone-treated cells in media ranging from pH 4.0
to 7.4. Maximal syncytia formation occurred at around pH 5.0 when
either the percentage of cells in syncytia or the number of nuclei in a
syncytia was measured; outside the pH 4.8 to 5.5 range, no fusion
occurred (Figs. 1B and C and not shown). These data indicated that
virus–cell fusion most likely occurred in late endosomes or lysosomes.
Low pH does not irreversibly inactivate MMTV
The Env proteins of viruses that require low pH to induce a
conformational change are often inactivated by low pH treatment
(termed premature triggering). To determine whether this was true
for MMTV, we created MMTV Env-pseudotyped MLV particles, as
previously described (Zhang et al., 2003) and incubated them at pH 5
for 15 min at 37 °C. The pseudoviruses were then used to infect 293T
cells stably expressing mTfR1 (mTfR1/293T) (Zhang et al., 2003). Low
pH (pH 5) pre-treatment had no effect on the infection levels (Fig. 2A),
indicating that the MMTV Env does not undergo an irreversible
change in the absence of receptor.
We also tested whether low pH treatment disrupted MMTV
interactionwith cells. Pseudovirions were bound to cells for 1 h at 4 °C
and then treated with different pH buffers. The infection levels were
the same when virus-bound cells were treated with pH 5, 6 and 7
buffer; only treatment with pH 3 buffer abolished infection (Fig. 2B).
Taken together, these data indicated that low pH does not cause pre-
triggering of the MMTV Env or dissociation from receptor.
MMTV trafﬁcs to both the early and late endosomes
TfR1 typically binds to holo-Tf and trafﬁcs to the early recycling
endosome (∼pH 6) where iron is released. The apo-Tf/receptor
complex then returns to the cell surface and releases Tf. We next
used immunohistochemistry to determine the intra-cellular location
of MMTV. NMuMG cells (normal mouse mammary gland cells that
express mTfR1) were incubated with MMTV on ice for 1 h, shifted to
37 °C for 15 min, then ﬁxed and immunostained with anti-MMTV and
anti-EEA1 or anti-rab 7 antibodies, which aremarkers of early and lateFig. 3.MMTV localizes to the early and late endosomes. NMuMG cells were incubatedwithM
immunostained with anti-EEA1 or with anti-rab7 antibodies. MMTV was detected by a moendosomal compartments, respectively. MMTV was detected in both
compartments, indicating that virus efﬁciently enters this pathway
and consistent with the pH 5 requirement for Env-mediated cell–cell
fusion (Fig. 3A). We also found that mTfR1 co-localized with a GFP-
tagged version of the early endosomal marker rab5 in the presence or
absence of virus, while it only was found in the same compartment as
a rab7-GFP (late endosomal marker) in the presence of virus (not
shown). This suggests that MMTV can re-direct trafﬁcking of mTfR1
from the early to late endosome.
MMTV infection requires trafﬁcking to a low pH compartment
Next, to determine whether MMTV infection required only low pH
and receptor or if trafﬁcking to an intra-cellular low pH compartment
was necessary, we tested if virus could enter cells at the plasma
membrane by treatment with low pH. We treated mTfR1/293T cells
with either nocodazole or baﬁlomycin A, both of which inhibit MMTV
infection (Fig. 4A and (Ross et al., 2002), incubated them with MMTV
at 4 °C, pulsed them with pH 5 or pH 7 buffer and then tested for
infection 2 days later by quantifying the level of MMTV DNA using
real-time quantitative PCR (RT-qPCR). Treatment with either drug
dramatically reduced the level of infection compared to cells that
underwent the same infection protocol in the absence of drug (Fig.
4B). We also tested whether MMTV required two-step activation of
fusion at the plasma membrane as is needed for ASLV (Barnard et al.,
2006; Delos et al., 2005; Matsuyama et al., 2004). MMTV was
incubated with mTfR1/293T cells at 37 °C for 1 h in the presence of
baﬁlomycin A, the mediawas removed and then the cells were treated
with pH 7 or pH 5 buffer for 15 min at 37 °C (Fig. 4C). Again, low pH
buffer was unable to rescue MMTV infection at the cell surface,
supporting the hypothesis that MMTV requires endosomal trafﬁcking
as well as low pH to achieve infection.
We next tested several molecules previously shown to disrupt
clathrin-mediated endocytosis of TfR1 for their effects on MMTV
infection. This included a dominant-negative Eps15 construct
(Benmerah et al., 1999) and a molecule termed Transferrin receptor
Trafﬁcking Protein (TTP; SH3BP4), over-expression of which has been
show to inhibit TfR internalization (Tosoni et al., 2005). mTfR1/293T
cells were transiently transfected with GFP-tagged versions of the
dnEps15 and TTP molecules and 24 h later, infected with MMTV andMTV (500 particles/cell) at 4 °C for 90min. Cells were then shifted to 37 °C for 15min and
noclonal antibody against the MMTV capsid protein (Case et al., 2005).
Fig. 4. MMTV requires trafﬁcking to a low pH compartment to infect cells. (A) mTfR1/
293T cells were treated with nocodazole at the indicated concentrations for 1 h and
then infected with MMTV pseudovirions in the presence of drug. (B) mTfR1/293T cells
were pretreatedwith either baﬁlomycin A (BFA) or nocodazole (noc) at 37 °C for 1 h. The
cells were then incubated with MMTV at 4 °C for 1 h, followed by treatment with
different pH buffers in presence of BFA or nocodazole at 37 °C for 15 min. The cells were
washed, incubated in media containing BFA or nocodazole for twomore hours and then
refed. Forty-eight hours later, DNA was isolated and subjected to RT-qPCR. (C) mTfR1/
293T cells were pretreated with BFA at 37 °C for 1 h, then incubated with MMTV at 37 °C
for 1 h, followed by treatment with different pH buffers in presence of BFA at 37 °C for
15 min. The cells were washed, incubated in media containing BFA for two more hours
and then refed. Forty-eight hours later, DNA was isolated and subjected to RT-qPCR.
Fig. 5. MMTV infects cells in the presence of a dominant-negative Eps15 molecule and
in cells over-expressing TTP. mTfR1/293T cells were transfected with the GFP-tagged
Eps15 or TTP molecule. In both cases, N50% of cells were transfected (right panel).
Twenty-four hours after transfection, the transfected cells, as well as untransfected
controls, were infected with MMTV Env- or VSV G-pseudovirions. Colonies were
counted 48 h later. Data is presented as the percent infection relative to untransfected
cells. Shown is the average of 2 wells; this experiment was repeated 3 times with
similar results.
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was greatly inhibited by the dnEps15 construct (Sun et al., 2005);
over-expression of TTP also inhibited VSV infection (Fig. 5). Incontrast, both molecules had only modest effects on MMTV infection
(Fig. 5).
Taken together, these data indicate that MMTV cannot infect cells
through the plasmamembrane, but instead require trafﬁcking to a low
pH compartment. Moreover, this trafﬁcking appears to be indepen-
dent of clathrin-mediated endocytosis.
MMTV infection does not depend on protease cleavage
Recently, the entry proteins of several pH-dependent viruses have
been shown to require cleavage by cathepsin cysteine proteases
located in the endosomal compartment to mediate membrane fusion.
We therefore tested several protease inhibitors for their effects on
MMTV pseudovirus infection: E64d (cysteine proteases), leupeptin
(endosomal trypsin-like serine and cysteine proteases), CA-074
(cathepsin B), Z-FY(t-Bu)-dmk (cathepsin L), aprotinin (serine-type
proteases) and pepstatin (aspartate proteases). VSV G pseudotypes
served as a negative control, Ebola virus GP pseudotypes as a positive
control. None of these inhibitors signiﬁcantly affectedMMTV infection
of either NMuMG (Fig. 6A) or mTfR1/293T (Figs. 6B and C) cells at the
highest concentrations tested. For example, 150 μM E64d inhibited
neither MMTV nor VSV pseudovirus infection (Figs. 6A and C), while
this concentration completely inhibited infection by Ebola virus G
protein pseudotypes (Fig. 6B); higher concentrations of E64d were
toxic to cells. Thus, the MMTV Env does not require cleavage by
proteases in a low pH compartment, at least in the two cell types
examined here.
MMTV Env causes fusion of human cells
Previous studies with enveloped viruses that enter from low pH
compartments have identiﬁed different requirements for entry. For
example, the fusion activity of the inﬂuenza HA can be triggered by pH
alone and does not depend on the presence of speciﬁc cell surface
proteins (Skehel and Wiley, 2000). For other viruses, like avian
sarcoma/leukemia virus (ASLV), receptor binding is needed to prime
the viral Env for subsequent low pH treatment (Mothes et al., 2000;
Delos et al., 2005). We next used Env-mediated syncytia formation to
determine if fusion of Env-mediated cell–cell fusion was TfR1- as well
as pH-dependent. We co-transfected 293T cells with expression
vectors containing the MMTV Env together with wild type hTfR1 or
a chimeric molecule, hTfR1-MTM52. MTM52 has a hTfR1 backbone,
but contains amino acids 285–296 and seven amino acid substitutions
Fig. 6. MMTV does not require cathepsin cleavage to infect cells. (A) NMuMG cells
grown in 24 well microtiter dishes were incubated with the indicated concentrations of
E64d 2 h prior to infection with MMTV or VSV pseudovirions. Shown is the average LFU
of 4 wells for each concentration of drug. This experiment was repeated 3 times with
similar results. (B) mTfR1/293T cells grown in 24 well microtiter dishes were incubated
with the indicated concentrations of E64d 2 h prior to infection with MMTV or Ebola
pseudovirions. Shown is the average LFU of 3 wells for each concentration of drug
normalized to the infection level for untreated cells in the same experiment. (C) mTfR1/
293T cells were treated with 59 μM leupeptin, 4 μM aprotinin, 36 μM pepstatin, 150 μM
E64d,100 μMCA-074 or 25 μMZ-FY(t-Bu)-dmk for 1 h prior to and during infectionwith
MMTV Env- or VSV G-pseudotyped MLV virus. Shown is the average LFU of 3 to 4 wells
for each concentration of drug normalized to the infection level for untreated cells in
the same experiment.
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these changes into the extra-cellular domain of hTfR1 renders it
capable of serving as an MMTV entry receptor (Wang et al., 2006).
Surprisingly, the MMTV Env induced syncytia formation to similar
extents in cells expressing either hTfR1 or MTM52; indeed, Env also
caused 293T cells expressing only endogenous levels of TfR1 to fuse
after pH 5 treatment (Fig. 7A). Moreover, the MMTV Env induced
syncytia on D17 dog and CFRK cat cells after pH 5 treatment (not
shown); neither the dog nor the cat TfR1 support MMTV pseudovirus
infection (Wang et al., 2006).To determine whether Env-mediated syncytia induction of
human cells relied on hTfR1, we grew Env-expressing 293T cells
in high iron, an established method for decreasing receptor
expression (Casey et al., 1989). Total and surface hTfR1 expression
levels, as determined by Western blot and FACS, respectively, were
diminished by at least 10-fold by this treatment, without affecting
Env expression (Fig. 7B). High iron treatment also abolished
syncytia induction (Fig. 7C). To control for non-speciﬁc effects of
high iron on syncytia formation, we also introduced a Moloney
murine leukemia virus Env that induces cell fusion at neutral pH
into 427 cells [293T cells expressing MCAT-1, the MoMLV receptor
(Chung et al., 1999)], and showed that it induced syncytia to a
similar extent in the presence and absence of iron (Fig. 7C).
We also tested whether MMTV Env required binding to receptor
in addition to low pH to induce syncytia. We transfected an
expression plasmid encoding an Env with point mutation in the
receptor binding site that abrogates MMTV pseudovirus binding
and infectivity (Zhang et al., 2003) into 293T cells and showed that
low pH/Env-dependent cell–cell fusion was completely abolished
(Fig. 7D). Thus, low pH alone was not sufﬁcient to induce the
conformational change in Env; receptor binding was also required
to achieve virus–cell membrane fusion.
MMTV Env binds hTfR1
We previously determined that two segments of mTfR1,
physically disparate from the Tf binding site but next to each
other on the crystal structure, were necessary to convert the hTfR1
into an MMTV entry receptor (Wang et al., 2006). Additionally,
sequence comparison and mutagenesis studies showed that all
functional MMTV entry receptors (mouse and rat) have a similar
pattern of charged amino acids in the binding site, compared to
nonfunctional receptors (human, cat, dog). However, the cell–cell
fusion data presented in the preceding section indicated that
MMTV might bind hTfR1. To determine if this was the case, we
performed co-transfection/co-immunoprecipitation studies with
expression plasmids encoding the MMTV Env, hTfR1 or MTM52
(Wang et al., 2006). When anti-MMTV Env antiserum was used for
the immunoprecipitation step and anti-hTfR1 antibodies for the
detection step, equal levels of both MTM52 and hTfR1 were
precipitated, even under high stringency conditions (0.5 M KI)
(Fig. 8). Thus, at least in an over-expression assay, both the hTfR1
and mTfR1 bind to the MMTV Env.
MMTV internalization occurs in cells expressing mTfR1 but not hTfR1
Although the MMTV Env bound hTfR1 and mediated cell fusion in
the presence of hTfR1, we have been unable to demonstrate that the
human receptor supports MMTV infection (Ross et al., 2002; Wang et
al., 2006; Zhang et al., 2003). Our data thus far indicated that during
infection, MMTV virions bound to mTfR1 on the cell surface are
endocytosed and trafﬁc to the late endosome or lysosome to reach
the correct pH compartment for entry. Previously, we showed that
MMTV binding to the surface of mouse cells resulted in decreased
surface expression of TfR1, indicating that the virus triggered
receptor internalization (Ross et al., 2002). To determine if MMTV
induced internalization of the hTfR1, 293T or mTfR1/293T cells
were spinoculated for 2 h at RT with MMTV virions, immunos-
tained with anti-human or anti-mouse TfR1 antibodies and
analyzed by FACS. MMTV infection down-regulated the levels of
mTfR1 on mTfR1/293T cells, but did not affect hTfR1 levels on
human 293T cells (Fig. 9A).
As a second assay to determine whether the hTfR1 supported
MMTV internalization, we used MMTV Env pseudotypes that
incorporated a MLV matrix (MA) protein tagged with GFP; similar
constructs have been used to follow HIV-1 entry in tissue culture cells
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2004). TheGFP-tagged pseudovirionswere incubatedwith either 293T
ormTfR1/293Tcells on ice for 1 h and then shifted to 37 °C for different
times. After incubation for 5minmost of the viruswas on the surface of
both the mTfR1/293T and 293T cells (Fig. 9B, panels a and c,respectively). After 30 min, the majority of virus bound to mTfR1/
293T cells was internalized (Fig. 9B, panel b). In contrast, the virus on
293T cells largely remained on the cell surface (Fig. 9B, panel d).
Together, these data indicated that MMTV binding to hTfR1 did not
trigger receptor endocytosis.
Fig. 7. The MMTV Env induces receptor-dependent fusion of human cells. (A) Human
293T were transiently transfected with the hTfR1 and the infection-competent mouse/
human hybrid MTM52 expression plasmids in the presence and absence of an Env
expression plasmid. Forty-eight hours post-transfection, the cells were treated with pH
5.0 media. Representative syncytia are marked by arrows. (B) 293T cells were grown in
the presence (−) or absence (+) of iron for 24 h, transiently transfected with the MMTV
Env expression plasmid and then grown for an additional day +/− iron. MMTV Env and
hTfR1 expression were analyzed byWestern blotting. hTfR1 cell surface expression was
analyzed by FACS using PE-conjugated anti-hTfR1 antibody; ﬁlled curve, unstained
cells; grey line, cells treated with iron; black line, untreated cells. (C) Env-transfected
293T cells, as described in A were grown in the absence (−) and presence (+) of iron.
293T cells were transfected with MMTV Env expression vector and treated with pH 5.0
media to induce syncytia or 427 cells transfected with MoMLV Q123 expression vector
were grown to conﬂuence. The enlarged area within the box is shown in the far right
panels. (D) Syncytia induction requires a receptor binding-competent Env. 293T cells
were transiently transfected with expression vectors encoding wild type Env or Env-FS,
which has a point mutation in the receptor binding site (Zhang et al., 2003). Low pH
treatment was performed 48 h after transfection Env and the number of syncytia/
20,000 cells was counted. Inset: Western blot analysis with anti-MMTV antiserum was
Fig. 8.MMTV SU binds both mTfR1 and hTfR1. (A) Human 293T cells were transfected
with Env, hTfR1 or MTM52 alone, or Env was co-transfected with hTfR1 and MTM52.
Immunoprecipitations of cell lysates were performed with goat anti-MMTV antiserum
and Western blots were probed with the anti-hTfR1 monoclonal antibody OKT-9 (IP);
cell lysates were also analyzed by Western blots to examine the level of TfR1
expression (lysates). The co-immunoprecipitations were performed at 4 °C in the
presence of 0.5 M KI.
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cells would allow infection by MMTV at the cell surface. 293T were
transfected with hTfR1 or MTM52 expression vectors and then
incubated with MMTV at 4 °C to allow binding. The cells were then
treated with pH 5, pH 6 or pH 7 media for 15 min at 37 °C and virus
was removed by washing; 48 h later, infection was analyzed by RT-
qPCR, using primers speciﬁc for the viral DNA. Although MMTV
infected MTM52-expressing cells under all conditions, we were
unable to detect infection of hTfR1-transfected 293T cells, even
though they expressed increased levels of hTfR1 compared to
untransfected cells (Fig. 10). Taken together, these results showed
that although MMTV binds human TfR1, it is only endocytosed when
bound to the infection-competent mouse receptor and thus cannot
use the human receptor for infection.
Discussion
The molecules that viruses bind on the cell surface constitute a
diverse collection of cellular proteins, carbohydrates, and lipids. These
receptors differ from one virus to the next and their expression ranges
from abundant and ubiquitous to limited and restricted. Some
molecules merely serve as attachment factors that concentrate viruses
on the cell's surface. Particularly for enveloped viruses, many receptors
not only bind viruses but induce conformational changes in the virus
attachment proteins that are required for virus entry. Other receptors
also guide bound viruses into endocytic pathways and may transmit
signals to the cytoplasm required for entry (Smith and Helenius, 2004).
Our data suggest that mouse TfR1 provides all three functions for
MMTV, virus attachment, induction of the Env conformational change
and trafﬁcking to a low pH compartment. Typically, receptors followFig. 9. Virus and receptor are internalized in cells expressing mouse but not the human
temperature for 2 h and then immunostained with PE-conjugated anti-human (293T) or a
unstained cells; light grey line, cells incubated with virus; solid black line, cells spinoculated
proteinwere incubated with either mTfR1/293T (a and b) or 293T (c and d) cells grown on gla
d). Cells were ﬁxed with paraformaldehyde and stained with rhodamine-conjugated phallothree potential routes after exiting the sorting endosome, trafﬁcking
either back to the cell surface via the recycling endosome, to the trans-
Golgi network or, if targeted for degradation to the late endosome/
lysosome (≤pH 5.5) (Gruenberg and Stenmark, 2004). In its normal
metabolic role, TfR1 trafﬁcs ﬁrst to the sorting endosome (∼pH 6)
upon binding diferric Tf and then moves either directly or via the
recycling endosome (also ∼pH 6) back to the surface where apo-Tf is
released. Given that MMTV Env-mediated membrane fusion occurs at
pH 5 but not pH 6 and its associationwith the late endosome (Fig. 3A),
it is likely that binding of virus re-targets TfR1 to this compartment.
Indeed, our preliminary studies indicate that this is the case (not
shown). MMTVmay re-direct TfR1 to the late endosome to gain better
access to the nucleus, since the sorting endosome is believed to be
located in the cell periphery, while the late and recycling endosomes
are found in the perinuclear region.
TfR1 endocytosis via clathrin-coated pits has been shown to
require a number of molecules, including TTP and Eps15. TTP is a
newly identiﬁed molecule which has been shown to be important for
internalization of TfR1, probably through its interactionwith dynamin
(Tosoni et al., 2005). We have also found that over-expression of a
dominant-negative form of dynamin had little or no effect on MMTV
infection (not shown). Eps15, which is associated with the adaptor
protein AP-2, has been implicated in the endocytosis and entry of a
number of enveloped viruses, including Sindbis virus and VSV
(Carbone et al., 1997; Sun et al., 2005). However, MMTV infection
occurred at almost wild type levels in cells expressing the dominant-
negative Eps15, indicating that its trafﬁcking to the late endosome is
largely independent of the normal endocytic pathway taken by TfR1.
Several other viruses, notably severe acute respiratory syndrome
(SARS) andmouse hepatitis virus 2 (MHV2), which like MMTV require
a bpH 5.5 compartment for entry, have recently been shown to infect
cells in the presence of the dominant-negative Eps15 (Pu and Zhang,
2008; Wang et al., 2008). Interestingly, it has been previously
suggested that intra-cellular trafﬁcking of TfR1 depends not only on
targeting sequences found in the receptor but also on the particular
ligand bound to the receptor, since a genetically engineered Tf that
bound to a different region of the receptor redirected it to the
lysosome and targeted it for degradation (Zaliauskiene et al., 2002).
Since MMTV interacts with a region of TfR1 distinct from Tf, it is
possible that the virus also re-directs the receptor from the early
recycling endosome to a more acidic compartment.TfR1. (A) 293T and mTfR1/293T cells were spinoculated with MMTV virions at room
nti-mouse (mTfR1/293T) TfR1 antibodies and subjected to FACS analysis. Dotted line,
in the absence of virus. (B) MMTV pseudovirions containing a GFP-tagged MLV matrix
ss slides on ice for 1 h. The cells were moved to 37 °C for 5min (a and c) or 30min (b and
idin and examined by ﬂuorescence microscopy. Magniﬁcation: 630×.
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Fig. 10. Low pH is not sufﬁcient to achieve MMTV infection of human cells. (A) 293T
were transfected with hTfR1 or MTM52, incubated with MMTV on ice, treated with
different pH buffers at 37 °C and then refed. After 48 h, DNAwas extracted and RT-qPCR
was performed with primers that amplify a region in the MMTV LTR; the MMTV signals
were normalized to GAPDH. (B) Western blot analysis of transfected cells.
238 E. Wang et al. / Virology 381 (2008) 230–240We show here that unlike many other enveloped viruses, while
binding to receptor and low pH are necessary, they are not sufﬁcient
for MMTV infection. Infection by several viruses, including Ebola, MLV,
Hendra and the SARS and MHV coronaviruses have been shown to
require cleavage by cysteine proteases located in the late endosome/
lysosome, such as cathepsin B and L, to achieve efﬁcient infection
(Chandran et al., 2005; Kaletsky et al., 2007; Kumar et al., 2007; Pager
and Dutch, 2005; Qiu et al., 2006; Schornberg et al., 2006; Simmons et
al., 2005). However, we found no evidence that MMTV required
cleavage by such enzymes, since neither speciﬁc inhibitors of
cathepsin (E46d) or more general protease inhibitors (leupeptin,
aprotinin, etc.) affected MMTV infection levels. Kumar et al. have also
suggested that MLV might require cathepsins at a post-membrane
fusion stage of infection, since they found that VSV G/MLV pseudotype
infection of NIH3T3 cells was inhibited by cathepsin inhibitor III and
CA-074 (Kumar et al., 2007). In our studies, VSV G/MLV pseudotype
infection was not affected by any of the cathepsin inhibitors; this
difference could be due to our use of NMuMG (mouse mammary
epithelial) and 293T (human kidney epithelial) cells as opposed to
NIH3T3 cells used in the previous study.
Our results also argue that MMTV cannot infect human cells using
the endogenous TfR1. Previously we showed that MMTV used mouse
but not human TfR1 as its entry receptor and that the regions of
receptor required for infectionmapped to two segments that formed a
potential binding site consisting of a unique charged amino acid-
distribution pattern (Wang et al., 2006). However, here we show that
MMTV binds both human and mouse TfR1 (Fig. 8) and that the Env
protein mediates cell–cell fusion in its presence at low pH (Fig. 7).
However, neither infectious virus particles nor pseudovirions were
capable of triggering receptor internalization (Fig. 9). Although the
MMTV Env binds hTfR1 even under high stringency conditions, it is
possible that binding is weaker than to the mouse receptor. Thus,
under the conditions of high Env expression achieved after transfec-
tion, therewould be a sufﬁcient number of Envmolecules that undergo
the conformational change required to induce Env-mediated cell–cell
fusion. Alternatively, MMTV may bind to a site on hTfR1 that does not
trigger receptor internalization via the YTRF motif in the cytoplasmic
tail; the YTRF motif has been shown to be important for Tf-mediated
TfR1 endocytosis via clathrin-coated pits (Collawn et al., 1993).
It is not surprising that low pH alone does not trigger an
irreversible conformational change in the MMTV Env, since the virus
is acquired through milk and must survive the low pH environment ofthe digestive tract. Importantly, we show here that to achieve entry,
MMTV must direct the TfR1 not to its normal recycling compartment,
but to a lower pH compartment such as the late endosome/lysosome.
Why does MMTV require trafﬁcking with TfR1 to a pH 5 compart-
ment? Clearly, neither receptor binding nor low pH is sufﬁcient, since
virus did not enter cells that express elevated levels of human or
mouse TfR1 at the cell surface even when incubated at pH 5. Marsh
and Bron have previously reported that fusion at the cell surface does
not allow Semliki Forest virus (SFV) infection and suggested that the
trafﬁcking to an endocytic compartment could provide a means for
bringing viral particles to sites in the cell where replication can
proceed (Marsh and Bron, 1997). It is also possible there are late
endosomal co-factors or co-receptors other than cathepsins that are
necessary for infection by MMTV and other viruses, a possibility
which is currently under investigation.
Materials and methods
Cell lines and plasmids
293T human kidney epithelial were grown in Dulbecco's modiﬁed
Eagle's medium containing 10% fetal bovine serum and penicillin/
streptomycin (50 μg/ml). mTfR1/293T (TRH3 in (Zhang et al., 2003)
and 427 (293T cells stably expressing murine leukemia virus receptor)
(Chung et al., 1999) cells were grown in the same medium
supplemented with geneticin (100 μg/ml) and NMuMG (normal
murine mammary gland) and Mm5MT cells in the same media
containing insulin (10 μg/ml). Plasmids pEnv and pEnv-FS containing
wild type MMTV env and an env with a mutation in the receptor
binding site, respectively, were previously described (Zhang et al.,
2003). Plasmid Q123 contains a variant MLV Env lacking the R peptide
that induces cell–cell fusion at neutral pH (Zavorotinskaya et al.,
2004). The GFP-tagged TTP, Eps15, rab5 and rab7 and hTfR1 and
MTM52 (an engineered human TfR1 that supports MMTV entry and
can be detected by the anti-hTfR1 monoclonal antibody OKT-9)
constructs were previously described (Tosoni et al., 2005; Benmerah
et al., 1999; Meertens et al., 2006; Wang et al., 2006).
Co-immunoprecipitations
Cells were transfected via the calcium phosphate method. Brieﬂy,
2×106 293T cells per well were seeded the day before transfection.
Twenty-four hours later, the cells were refed with medium containing
10 ng/ml sodium butyrate to induce expression of the CMV promoter-
driven genes. Twenty-four hours later, cell lysates were prepared by
incubating cells in 0.5 M KI co-immunoprecipitation buffer (20 mM
Tris–Cl, pH 7.5, 0.5 M KI, 1% NP-40, 1 mM EDTA, 1 μg/ml Protease
inhibitor cocktail, Sigma at St. Louis, MO). Goat anti-MMTV antisera
was added to the lysates and incubated overnight at 4 °C. The immune
complexes were precipitated with Protein G agarose (Invitrogen,
Carlsbad, CA) and proteins eluted in SDS-protein loading buffer. The
proteins were resolved by SDS-polyacrylamide gels (SDS-PAGE) and
analyzed by Western blotting, as previously described (Zhang et al.,
2003). Hybridoma supernatant OKT-9 (a gift from Morrie Birnbaum)
was used to detect hTfR1 and MTM52 and monoclonal anti-SU to
detect MMTV. For whole cell lysates, the blots were stripped and
probed with anti-human beta-actin (Santa Cruz Biotechnology, Inc.).
Virus entry assays
GFP-labeled MMTV Env-pseudotyped MLV recombinant viruses
were produced by transient co-transfection of 293T cells with plasmid
pENV, pHit111 (murine leukemia virus [MLV] genome with the β-
galactosidase marker), pHit60 (MLV gag/pol genes) (Soneoka et al.,
1995), and Matrix-GFP (the MLV matrix protein with an in-frame
fusion to E-GFP) as previously described (Golovkina et al., 1998). The
239E. Wang et al. / Virology 381 (2008) 230–240supernatant was harvested at 48 h post-transfection and concentrated
by ultracentrifugation, 25,000 rpm for 2 h in an SW28 rotor at 4 °C.
Virus titers were measured by counting β-galactosidase-positive
colonies (reported as LacZ-forming units (LFU) or ﬂuorescence
microscopy to detect GFP-positive colonies. For examining virus
entry, the GFP-labeled virus was incubated with either 293T cells or
mTfR1/293T cells in the presence of 8 μg/ml polybrene at 4C for 1 h.
The cells were then shifted to 37 °C for 5 or 30 min, as indicated in the
ﬁgure legend, washed with cold phosphate-buffered saline (PBS),
ﬁxed with 4% paraformaldehyde and stained with rhodamine
phalloidin (Molecular Probes, Inc., Eugene, Oregon). Cells were
visualized by ﬂuorescence microscopy (Axioplan 2 Imaging, ZEISS,
Inc., Denver, CO).
Immunohistochemistry
NMuMG cells seeded on collagen Type I Cellware 8-well Culture-
Slide (BD Biosciences, Bedford, MA, USA) were incubatedwith virus on
ice for 1 h, then shifted to 37 °C for 15min. The cells were ﬁxedwith 3%
paraformaldehyde in PBS (pH 7.4) for 15 min, quenched with 50 mM
NH4Cl, and permeabilized with 0.1% Triton X-100. After blocking with
10% goat serum, the cells were incubated with primary and secondary
antibodies for 30 min each and mounted DAPI-containing mounting
medium (Vector Laboratories, Inc. Burlingame, CA). The MMTV capsid
proteinwas detected using a monoclonal antibody kindly provided by
Dr. Tatyana V. Golovkina. Early and late endosomes were detected by
goat anti-mouse polyclonal IgGs against early endosome autoantigen
1 (EEA1) and Rab7 (Santa Cruz Biotechnology, INC. Santa Cruz, CA,
USA), respectively. Secondary antibodies used were Alexa Fluor 568
(red) goat anti-mouse IgG (Molecular Probes, Eugene, Oregon, USA) or
ﬂuorescein (FITC)-conjugated afﬁnity pure donkey anti-goat IgG
(Jackson ImmunoResearch Laboratories, INC. West Grove, PA). Cells
were viewedwith a 63× objective lens and images were captured with
Slidebook 3.0 software (Leeds Precision Instruments, Inc. Minneapolis,
MN) before being transferred into Adobe Photoshop.
Receptor internalization assay
Virions were obtained from the NCI repository and stored at -70 °C.
Infection of 293T and mTfR1/293T cells was performed with 500 virus
particles/cell by spinoculation in the presence of 8 μg/ml polybrene, as
previously described (Zhang et al., 2003) at either room temperature
or 4 °C. Cells were stained with phycoerythrin (PE)-conjugated anti-
human CD71 (BD Pharmingen, Inc., location) or anti-mouse CD71 (BD
Pharmingen, Inc.) to detect TfR1 levels on 293T or mTfR1/293T cells,
respectively and analyzed by FACS analysis as described above.
Cell–cell fusion assays
Mm5MT cells were grown in 0.5 μM dexamethasone 24 h prior to
fusion induction to increase cell surface Env expression. 293T, CRFK
and D17 cells were transfected with MMTV Env, hTfR1, MTM52 or Env
+hTfR1, Env+MTM52 plasmids and 48 h post-transfection, cells were
treated with citrate buffer at the pH indicated in the ﬁgure legend for
15 min to induce fusion. The cells were refed with growth medium
and incubated at 37 °C overnight, washed with PBS and stained with
Giemsa-Wright. The number of syncytia in each well was counted and
number of syncytia/number of total cells was used to quantitate the
cell–cell fusion.
Infection assays
293T cells were transfected with a mTfR1 expression plasmid, as
described above. Twenty-four hours post-transfection, diluted pseu-
dovirus supernatants containing polybrene (8 μg/ml) were incubated
with cells at 37 °C for 2 h. The cells were stained for β-galactosidaseactivity 48 h after infection, and blue colonies were counted. Data are
presented as LacZ-forming units (LFU) per ml of supernatant. For the
protease inhibitor experiments, NMuMG or mTfR1/293T cells were
infected with MMTV, VSV or Ebola pseudoviruses. E64d, leupeptin,
CA-074, Z-FY(t-Bu)-dmk, aprotinin and pepstatin were added to the
infection media at the indicated concentrations for 2 h prior to and
during the 2 h incubation with virus. The cells were washed and
stained for β-galactosidase activity 48 h post-infection.
Low pH infection assay
293T and mTfR1/293T cells were incubated with virus (500 virus
particles/cell) at 4 °C or 37 °C for 1 h. The cells were washed with cold
PBS and then different pH (pH 5, 6, 7) citrate buffer (40 mM sodium
citrate, 10 mM KCl, 135 mM NaCl) were used to treat the cells for
15 min at 37 °C. Fresh media was added to the cells. Forty-eight hours
post-infection, DNA was extracted with DNAEasy kit (Qiagen, Inc.,
Maryland) and subjected to real-time quantitative PCR (RT-qPCR).
MMTV primers that amplify the MMTV(C3H) LTR were used to detect
infection, as previously described (Courreges et al., 2007). Primers to
GAPDH were used to normalize input DNA.
Receptor down-regulation
Duplicate cultures of 293T and 427 cells were incubated with ferric
ammonium citrate (100 μg/ml) (FeAC) for 24 h prior to transfection.
The cells were washed and transfected with plasmids pENV or Q123.
Twelve hours post-transfection, the cells were refed with media
containing FeAC. Twenty-four hours later, one culture was used for
cell–cell fusion assay, as described above. A second culturewas used to
determine total TfR1 levels byWestern blotting with OKT-9 or surface
TfR1 levels by FACS with phycoerythrin-conjugated anti-human CD71
antibodies.
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